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ABSTRACT
Endonuclease (Endo) IV encoded by denB of
bacteriophage T4 is an enzyme that cleaves
single-stranded (ss) DNA in a dC-specific manner.
Previously we have demonstrated that a dTdCdA is
most preferable for Endo IV when an oligonucleotide
substrate having a single dC residue is used. Here
we demonstrate that Endo IV cleaves ssDNAs
exclusively at the 5’-proximal dC where a sequence
comprises dC residues both at the 5’ proximal and
3’ proximal positions (a dCs tract-dependent clea-
vage). The dCs tract-dependent cleavage is efficient
and occurs when a dCs tract has at least 6 bases.
Some dCs tracts larger than 6 bases behave as that
of 6 bases (an extended dCs tract), while some
others do not. One decameric dCs tract was shown
to be cleavable in a dCs tract-dependent manner,
but that with 13 dCs was not. The dCs tract-
dependent cleavage is enhanced by the presence
of a third dC residue at least for a 6 or 7 dCs tract. In
contrast to the dCs tract-dependent cleavage, a dCs
tract-independent one is generally inefficient and
if two modes are possible for a substrate DNA, a
dCs tract-dependent mode prevails. A model for the
dCs tract-dependent cleavage is proposed.
INTRODUCTION
Endonuclease (Endo) IV encoded by denB of bacterio-
phage T4 is a unique enzyme that cleaves single-stranded
(ss) DNA in a dC-speciﬁc manner (1–5). Only limited
information on the mechanism of substrate recognition by
Endo IV has been available (1–4) and the small number of
Endo IV-related proteins in the genome sequence data-
bases have limited the amount of insight provided by such
proteins into mechanisms of Endo IV action. Given that
Endo IV is highly toxic to Escherichia coli cells, we have
synthesized the enzyme with the use of a wheat germ
cell-free protein synthesis system (6) and puriﬁed it to
homogeneity (5). Endo IV requires Mg
2+ for activity, acts
on ssDNA, generates 50 termini containing exclusively dC
(1,3,5) and does not cleave normal T4 genomic DNA con-
taining glucosylated deoxyhydroxymethylcytidine (1,5).
In addition, the enzyme processed both phiX174
circular ssDNA and heat-denatured T4dC genomic
double-stranded (ds) DNA substrates to oligonucleotides
comprising several hundred bases (5), suggesting that the
digestion of dC sites was highly restricted in each substrate
and that the sequence surrounding dC residues or the
size of dC-containing oligonucleotides might aﬀect the
cleavage eﬃciency. To characterize the mode of endonu-
cleolytic cleavage by Endo IV, we used two methods;
an acid-solubility assay of oligonucleotide substrates and
a cleavage pattern analysis of Cy5-labeled substrates.
The acid-solubility assay is based on the activity of Endo
IV to generate acid-soluble products from an acid-
insoluble oligonucleotide substrate. We synthesized oligo-
nucleotide substrates that consist of two dA-copolymers
adjacently placed to the 50- and 30-ends of a central target
sequence. The substrates used were so designed as to
become acid-soluble when cleaved in the target sequence
by Endo IV. The enzymatic activity of Endo IV was
deﬁned as the ability to generate acid-soluble products
from an acid-insoluble substrate. The rationale of this
method was described in detail (5). We successfully
quantiﬁed Endo IV activity using oligonucleotide sub-
strates with a single dC residue and found a marked
preference of Endo IV for the sequence 50-dTdCdA-30 (5).
The cleavage pattern analysis of Cy5-labeled substrates
gives us information as to the actual sites as well as
cleavage eﬃciencies (5).
Here we used several Cy5-labeled oligonucleotide
substrates based on T4 genomic sequence and phiX174
ssDNA sequence in addition to the acid-solubility assay,
and we found that the cleavage events occur at the limited
dC sites in which a sequence tract comprising dC residues
at both the 50- and 30-proximal positions. The feature
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basis of the acid-solubility assay and cleavage analysis of
Cy5-labeled oligonucleotides are as follows: Endo IV
recognizes a hexanucleotide consisting of two dC residues
at the ﬁrst and sixth positions, named a 6 dCs tract
(dC1–dC6 tract), in which the cleavage event occurs exclu-
sively at the dC1 site. A third dC residue placed within
ad C 1–dC6 tract improves aﬃnity between the substrate
and Endo IV. Furthermore, some dCs tracts larger than
6 bases (an extended dCs tract) have been shown to
behave as a cleavable dCs tract while some others do not.
A decameric dCs tract works as an extended dCs tract
cleavable by Endo IV. A model for the dCs tract-
dependent cleavage by Endo IV is presented.
MATERIALS AND METHODS
Materials
Restriction and other enzymes for recombinant DNA
technology were obtained from Takara Shuzo. The
plasmid pEUGFP was constructed as described previously
(7) and pGEX-6p-1 was obtained from GE Healthcare.
Oligonucleotides used for the acid-solubility assay in this
article were purchased from OligoTexas Co. and are listed
in Table 1. Five Cy5-labeled oligonucleotides, Cy5-T4A,
Cy5-T4B, Cy5-T4BG, Cy5-T4Be1 and Cy5-T4Be2 are
based on the sequence of T4 DNA. Two Cy5-labeled oli-
gonucleotides, Cy5-phiX174-6 and Cy5-phiX174-6b, are
based on the sequence of phiX174 ssDNA. Cy5-phiC174-6
is the same as used in the cleavage experiment of Figure 3
in the previous paper (5). All of these oligonucleotides
labeled at their 50-end with Cy5 were commercially synthe-
sized (Sigma-Aldrich, Japan). Cy5-T4A, 50-dTdAdGdAdT
dTdTdAdGdTdAdAdTdTdAdTdAdTdGdCdTdCdTdTd
CdAdTdTdAdGdAdAdAdAdAdTdTdAdTdTdTdGdTd
GdA-30; Cy5-T4B, 50-dAdTdTdGdGdAdAdAdCdTdTdA
dAdTdGdTdAdAdTdTdCdAdCdTdTdCdAdTdTdGdCd
GdAdAdTdGdCdTdTdAdGdCdCdAdG-30; Cy5-T4BG,
50-dAdTdTdGdGdAdAdAdCdTdTdAdAdTdGdTdAdA
dTdTdCdAdCdTdTdCdAdTdTdGdGdGdAdAdTdGdC
dTdTdAdGdCdCdAdG-30; Cy5-T4Be1, 50-dAdTdTdGd
GdAdAdAdCdTdTdAdAdTdGdTdAdAdTdTdCdAdCd
GdTdTdCdAdTdTdGdCdGdAdAdTdGdCdTdTdAdGd
CdCdAdG-30; Cy5-T4Be2, 50-dAdTdTdGdGdAdAdAdC
dTdTdAdAdTdGdTdAdAdTdTdCdAdGdGdTdTdCdA
dTdTdGdCdGdAdAdTdGdCdTdTdAdGdCdCdAdG-30;
Cy5-phiX174-6, 50-dTdTdGdGdAdTdGdAdGdGdAdGd
AdAdGdTdGdGdCdTdTdAdAdTdAdTdGdCdTdTdGd
GdCdAdCdGdTdTdCdGdTdCdAdAdG-30; Cy5-phiX174 -6b,
50-dTdTdGdGdAdTdGdAdGdGdAdGdAdAdGdTdGdGdCd
TdTdAdAdTdAdTdGdGdTdTdGdGdCdAdCdGdTdTdCdGd
TdCdAdAdG-30.
Production andpurification of GST-Endo IV fusion protein
A DNA fragment encoding a GST fusion protein of Endo
IV was constructed and subjected to in vitro transcription
as described previously (5). The resulting mRNA was
then translated in a wheat germ cell-free protein synthesis
system with the use of a dialysis cup (molecular size cutoﬀ
of 12000Da; Daiichi Pure Chemicals) as described
previously (5). The dialysis unit containing the reaction
mixture was incubated for 96h at 268C, with the original
amount of substrate mRNA being supplemented and the
external solution changed every 24h. The GST-Endo IV
fusion protein was puriﬁed as described previously (5).
The fusion protein was cleaved by incubation with
PreScission protease (10U/ml; GE Healthcare) for 4h at
48C in a glutathione-Sepharose 4B MicroSpin column
(GE Healthcare). The ﬂow-through fraction contained
a protein of the predicted size for Endo IV (21.1kDa),
as revealed by SDS–polyacrylamide gel electrophoresis
on a 12% gel and staining with Coomassie brilliant blue.
The protein concentration of this fraction was estimated
by densitometric analysis with NIH Image software and
the use of trypsin inhibitor (20.1kDa) as a standard.
Kinetic analysis of Endo IV activity
Hydrolysis of oligonucleotide substrates (10mM) was
performed by the acid-solubility assay as described
previously (5). Enzyme and substrate were incubated for
30min at 378C in a reaction mixture (20ml) containing
10mM Tris–HCl (pH 8.0), 10mM MgCl2, 1mM dithio-
threitol and bovine serum albumin (0.1mg/ml). The
reaction was stopped by the addition of 30mlo f2 5 m M
EDTA (pH 8.0) and 50ml of 10% trichloroacetic acid.
The resulting mixture (100ml) was maintained on ice for
15min and then centrifuged at 5000g for 15min at 48C.
The amount of acid-soluble nucleotide in the supernatant
fraction was quantiﬁed by measurement of absorbance
at 260nm, with molar absorption coeﬃcients of 15 200,
Table 1. Oligonucleotide substrates used and their abbreviated names
Oligonucleotide Short name
50-(dA)5(dC)15(dA)5-30 [(dC)15]15/25
50-(dA)7(dC)11(dA)7-30 [(dC)11]11/25
50-(dA)9(dC)7(dA)9-30 [dCdCdCdCdCdCdC]7/25
50-(dA)9(dC)6(dA)10-30 [dCdCdCdCdCdC]6/25
50-(dA)10(dC)5(dA)10-30 [dCdCdCdCdC]5/25
50-(dA)12(dC) (dA)12-30 [dC]1/25
50-(dA)9dCdTdTdTdTdC(dA)10-30 [dCdTdTdTdTdC]6/25
50-(dA)9dCdCdTdTdTdC(dA)10-30 [dCdCdTdTdTdC]6/25
50-(dA)9dCdTdCdTdTdC(dA)10-30 [dCdTdCdTdTdC]6/25
50-(dA)9dCdTdTdCdTdC(dA)10-30 [dCdTdTdCdTdC]6/25
50-(dA)9dCdTdTdTdCdC(dA)10-30 [dCdTdTdTdCdC]6/25
50-(dA)9dCdAdAdAdAdC(dA)10-30 [dCdAdAdAdAdC]6/25
50-(dA)9dCdAdCdAdAdC(dA)10-30 [dCdAdCdAdAdC]6/25
50-(dA)9dCdGdGdGdGdC(dA)10-30 [dCdGdGdGdGdC]6/25
50-(dA)9dCdGdCdGdGdC(dA)10-30 [dCdGdCdGdGdC]6/25
50-(dA)9dCdCdAdTdTdC(dA)10-30 [dCdCdAdTdTdC]6/25
50-(dA)9dCdCdTdAdTdC(dA)10-30 [dCdCdTdAdTdC]6/25
50-(dA)9dCdCdTdTdAdC(dA)10-30 [dCdCdTdTdAdC]6/25
50-(dA)10dCdTdTdTdC(dA)10-30 [dCdTdTdTdC]5/25
50-(dA)9dCdTdTdTdTdTdC(dA)9-30 [dCdTdTdTdTdTdC]7/25
Suﬃx numbers indicate the nucleotide length of the target sequence
(referred as a six-base tract) and total length of oligonucleotides,
respectively. Suﬃx number is often omitted in the text. A dC1–dC6 tract
is deﬁned as a hexanucleotide comprising two dC residues at the ﬁrst
and sixth positions and the sequences are shown in the parentheses [ ].
All of the oligonucleotides in the table were acid-insoluble as their
intact form and the cleavage products became acid-soluble by extensive
treatment with Endo IV.
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 1 for dA, dC, dG and dT,
respectively. One unit was deﬁned as the amount of
enzyme producing 1mmol of acid-soluble nucleotides per
minute, and speciﬁc activity was deﬁned as the enzymatic
activity per milligram of enzyme. The amount of enzyme
was varied such that the amount of product increased in
proportion to that of the enzyme. The concentration
of the substrate was also varied from 3 to 30mM such
that it spanned the Km. Oligonucleotide substrates were
synthesized by Texas Genomics, Japan. Kinetic param-
eters were determined by a least-squares ﬁt of the data
in Lineweaver–Burk plots.
Cleavage pattern analysis of Cy5-labeled oligonucleotides
Hydrolysis of Cy5-labeled oligonucleotides was performed
as described above for the Endo IV assay at a substrate
concentration of 10mM. Two kinds of cleavage conditions
were adopted for detecting cleavage bands. For a low
Cy5-speciﬁc activity cleavage, Cy5-labeled oligonucleo-
tides (10mM) were diluted with an equal volume of non-
Cy5-labeled oligonucleotides having an identical sequence
and concentration. For a high Cy5-speciﬁc activity
cleavage, Cy5-labeled oligonucleotides (10mM) commer-
cially supplied were used without diluting by non-labeled
oligonucleotides. Cleavages of oligonucleotides with a low
Cy5-speciﬁc activity were performed with varied enzyme
concentration (0.5–4mg/ml). Cleavages of oligonucleotides
with a high Cy5-speciﬁc activity were done at an enzyme
concentration of 0.66mg/ml. The reaction products were
separated by electrophoresis on a 10% polyacrylamide gel
containing 7M urea and were visualized with a Variable
Image Analyzer Typhoon 8600 (GE Healthcare).
RESULTS
A hexanucleotide (dC1–dC6tract)is abasic framework
foran efficient cleavage by EndoIV
A dC-homopolymer, (dC)45, was eﬃciently cleaved by
Endo IV while three other homopolymers ((dA)45, (dG)45
and (dT)45) were not (5), being consistent with the notion
that Endo IV cleaves ssDNA by an exclusively dC-speciﬁc
manner (1,3,5). To know the basic feature of dC-speciﬁc
cleavage by Endo IV, we examined the cleavage activity
using various oligonucleotides as the substrates (Table 1).
The activity of Endo IV reduced gradually as the number
of dC residues in the 25-base oligonucleotide substrate
decreased from 25 to 6 and then markedly declined as
the number of dC residues decreased from six to ﬁve
(Table 2). The Vmax value (3.3U/mg) of Endo IV with a
substrate ([dCdCdCdCdCdC]6/25) containing six consecu-
tive dC residues within a target site was comparable to
that with [dCdCdCdCdCdCdC]7/25. On the other hand,
the Vmax value with a substrate containing ﬁve consecutive
dC residues ([dCdCdCdCdC]5/25) was signiﬁcantly low
(0.38U/mg) and the same level to that apparent with
[dC]1/25. In addition, the aﬃnity of oligonucleotide
substrate (Km value) to Endo IV became weaker by the
size of dC residues in the target site of the substrate
decreasing from six to ﬁve. Although the acid-solubility
assay does not give us information of the cleavage site in
these oligonucleotide substrates by Endo IV, these results
strongly suggest that the size of dC-containing target in an
oligonucleotide substrate used must be longer than 6 bases
for an eﬃcient cleavage by Endo IV. Although we have
not examined extensively, an oligonucleotide substrate,
[dCdTdTdTdTdTdC]7/25 gives Vmax and Km values com-
parable to those of dC1–dC6 tracts (Table 3), at least some
of 7 dCs tract (dC1–dC7 tract) behave like a 6 dCs tract.
For dCs tracts larger than 6 bases (referred as extended
dCs tracts) will be described below.
Furthermore, since the kinetic parameters of Endo IV
with [dCdCdCdCdCdC]6/25 were signiﬁcantly more favor-
able than those with [dCdCdCdCdC]5/25, we assumed that
at least two dC residues at the ﬁrst and sixth positions of a
6-base tract (dC1–dC6 tract) in the oligonucleotide
substrate might be crucial for an eﬃcient cleavage by
Endo IV. To test this assumption, we examined the kinetic
parameters of Endo IV with oligonucleotide substrates
in which the internal positions (dN2dN3dN4dN5)o fa
dC1–dC6 tract were replaced with dA, dG or dT (Table 2).
The Vmax values with [dCdTdTdTdTdC]6/25, [dCdAdAdA
dAdC]6/25 and [dCdGdGdGdGdC]6/25 were 1.8, 2.6 and
Table 3. Kinetic parameters of Endo IV with various dC1–dC6 tracts
and the eﬀects of third dC residue in the tracts
Oligonucleotide Vmax (U/mg) Km (mM)
[dCdCdCdCdCdC]6/25 3.3 (1.00) 5.8 (1.00)
[dCdTdTdTdTdC]6/25 1.8 (0.55) 8.8 (1.52)
[dCdCdTdTdTdC]6/25 4.4 (1.33) 5.4 (0.93)
[dCdTdCdTdTdC]6/25 4.6 (1.39) 6.0 (1.03)
[dCdTdTdCdTdC]6/25 1.7 (0.51) 5.0 (0.86)
[dCdTdTdTdCdC]6/25 1.7 (0.51) 5.8 (1.00)
[dCdAdCdAdAdC]6/25 2.6 (0.79) 5.4 (0.93)
[dCdGdCdGdGdC]6/25 2.8 (0.85) 6.8 (1.17)
[dCdCdAdTdTdC]6/25 3.0 (0.91) 5.2 (0.90)
[dCdCdTdAdTdC]6/25 2.1 (0.64) 4.9 (0.84)
[dCdCdTdTdAdC]6/25 4.3 (1.30) 5.4 (0.93)
[dTdCdAdCdTdTdC]7/25 7.1 (2.15) 4.8 (0.83)
[dCdTdTdTdTdTdC]7/25 2.3 (0.70) 12.6 (2.20)
[dCdCdCdCdCdCdC]7/25 3.2 (0.97) 6.3 (1.09)
The Vmax and Km values of Endo IV were determined with the
indicated oligonucleotides shown by short names (Table 1). Others are
the same as described in Table 2.
Table 2. Kinetic parameters of Endo IV with oligonucleotide substrates
containing a target sequence
Oligonucleotide Vmax (U/mg) Km (mM)
[(dC)15]15/25 14.0 (4.24) 6.0 (1.03)
[(dC)11]11/25 6.1 (1.85) 5.1 (0.88)
[dCdCdCdCdCdCdC]7/25 3.2 (0.97) 6.3 (1.09)
[dCdCdCdCdCdC]6/25 3.3 (1.00) 5.8 (1.00)
[dCdCdCdCdC]5/25 0.38 (0.11) 12.6 (2.17)
[dC]1/25 0.40 (0.12) 14.1 (2.43)
[dCdTdTdTdTdC]6/25 1.8 (0.55) 8.8 (1.52)
[dCdAdAdAdAdC]6/25 2.6 (0.79) 8.8 (1.52)
[dCdGdGdGdGdC]6/25 2.7 (0.82) 9.3 (1.60)
The Vmax and Km values of Endo IV were determined with the
indicated oligonucleotides shown by short names (Table 1). The relative
values were calculated by dividing the values for each substrate by
those for [dCdCdCdCdCdC]6/25 and shown in the parentheses ( ). Data
are means of two independent experiments.
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with [dCdCdCdCdCdC]6/25, but signiﬁcantly higher than
that with [dCdCdCdCdC]5/25, supporting the notion
that two dC residues in the ﬁrst and sixth positions of a
dC1–dC6 tract are crucial for an eﬃcient cleavage by Endo
IV. We therefore adopted [dCdTdTdTdTdC]6/25 as the
basic conﬁguration of the substrate to scan for dC residues
that aﬀect the kinetic parameters of Endo IV.
Effects of athirddC residue withinadC1–dC6tract on
thekinetic parametersof Endo IV
The Km values with [dCdTdTdTdTdC]6/25, [dCdAdAdA
dAdC]6/25 and [dCdGdGdGdGdC]6/25 were consistently
higher than that with [dCdCdCdCdCdC]6/25 (Table 2).
Therefore, we assumed that an additional dC residue in
the dC1–dC6 tract might aﬀect the enzyme-substrate
aﬃnity (Km value). To know the eﬀect of an additional
(third) dC residue within the dC1–dC6 tract, we deter-
mined the kinetic parameters for hydrolysis of oligonu-
cleotide substrates, in which one of the dT residues of
[dCdTdTdTdTdC]6/25 was replaced with a dC residue.
The Km values with [dCdCdTdTdTdC]6/25, [dCdTdCd
TdTdC]6/25, [dCdTdTdCdTdC]6/25 and [dCdTdTdTd
CdC]6/25 oligonucleotides were reduced compared to that
with [dCdTdTdTdTdC]6/25, indicating that an additional
dC residue in a dC1–dC6 tract improves the enzyme-
substrate aﬃnity to the level of that with [dCdCdCdCd
CdC]6/25. This is also the case with derivatives of [dCdAd
AdAdAdC]6/25 and [dCdGdGdGdGdC]6/25, in which
one of the internal dA or dG was replaced with a dC
residue (Table 3).
The Vmax values with [dCdCdTdTdTdC]6/25 and [dCdT
dCdTdTdC]6/25 were 2.4- and 2.6-fold higher than that
with [dCdTdTdTdTdC]6/25, while those with [dCdTdTdC
dTdC]6/25 and [dCdTdTdTdCdC]6/25 oligonucleotides
were almost the same level as that with [dCdTdTd
TdTdC]6/25 (Table 3). To analyze why [dCdCdTdTdT
dC]6/25 and [dCdTdCdTdTdC]6/25 were more susceptible
to cleavage by Endo IV than others, we ﬁrst determined
the kinetic parameters for the hydrolysis of 50-(dA)9dCd
RdRdRdRdC(dA)10-30 (= [dCdRdRdRdRdC]6/25, where
dR represents dA or dG) and of 50-(dA)9dCdRdCdRdR
dC(dA)10-30 (= [dCdRdCdRdRdC]6/25) series of oligonu-
cleotides. The Vmax values with [dCdRdCdRdRdC]6/25
were not markedly increased compared with those with
[dCdRdRdRdRdC]6/25 (Table 3), indicating that the
hydrolysis rate of Endo IV with [dCdDdCdDdDdC]6/25
is greater when dD represents dT than when it represents
dA or dG.
To identify the dT residues of [dCdCdTdTdTdC]6/25
and [dCdTdCdTdTdC]6/25, which aﬀect the susceptibility
to Endo IV cleavage, we determined the kinetic param-
eters for hydrolysis of [dCdCdAdTdTdC]6/25, [dCdCd
TdAdTdC]6/25 and [dCdCdTdTdAdC]6/25 oligonucleo-
tides. The Vmax value with the sequence [dCdCdTdT
dAdC]6/25 containing the trinucleotide, 50-dCdTdT-30, was
2.4-fold greater than that apparent with [dCdTdTdT
dTdC]6/25 (Table 3). Given that, in addition to [dCdCdTd
TdAdC]6/25, both [dCdCdTdTdTdC]6/25 and [dCdTdCd
TdTdC]6/25 contain the 50-dCdTdT-30 sequence, this
trinucleotide within a dC1–dC6 tract enhances the cleavage
activity as well as the enzyme-substrate aﬃnity. These
results indicate that a third dC residue within a dC1–dC6
tract may enhance the cleavage eﬃciency by Endo IV.
Cleavage of adC1–dC6tract by Endo IV occurs
at dC1site (polarized cleavage)
To know the dC residue whose 50 phosphodiester bond is
cleaved by Endo IV in the dC1–dC6 tract, we examined the
cleavage pattern of a Cy5-labeled 45-base oligonucleotide
based on a T4 DNA sequence which contains a 50-dCd
TdCdTdTdC-30 hexameric tract in the middle portion of
the oligonucleotide (Cy5-T4A). This oligonucleotide is
comparable to [dCdTdCdTdTdC]6/25 used for the acid-
solubility assay in the previous section. The oligonucleo-
tide [dCdTdCdTdTdC]6/25 is one of the optimal substrates
for Endo IV having a hexameric dCs tract with a third dC
(Table 3), we are able to know the exact cleavage position
(s) in the 6 dCs tract using Cy5-T4A. As a result, cleavages
occurred eﬃciently at dC20, but very slightly if any at dC22
and dC25 (Figure 1). It is remarkable that an eﬃcient
cleavage occurred exclusively at the ﬁrst dC (dC20) in spite
of three possible cleavage sites within the 6 dCs tract
(a dC20–dT21–dC22–dT23–dT24–dC25). The eﬃcient clea-
vage of the 6 dCs tract within Cy5-T4A is consistent with
the result obtained by the acid-solubility assay (Table 3),
and strongly suggests that an eﬃcient cleavage within a
6 dCs occurs at the 50-proximal end (dC1 position) even
in the oligonucleotide [dCdTdCdTdTdC]6/25 used for the
acid-solubility assay. Although the acid-solubility assay
used in the kinetic analysis by Endo IV does not provide
the cleavage site of substrates with a dCs tract, it is
reasonable to assume that cleavage events occur at the ﬁrst
dC (dC1) position within the target tract of oligonucleo-
tide substrates used.
To conﬁrm the assumption that Endo IV cleaves
ssDNAs at the dC1 position in a dC1–dC6 tract-depending
manner (6 dCs tract-dependent polarized cleavage), we
performed a series of cleavage experiments using Cy5-
labeled oligonucleotides. Cy5-T4B is a 45mer Cy5-labeled
oligonucleotide based on the T4 sequence, having two
consecutive hexameric dCs tracts, dC21dA22dC23dT24
dT25dC26, and dC26dA27dT28dT29dG30dC31 in the middle
portion of the oligonucleotide (Figure 1). Cy5-T4B has
8 dC residues in the 45nt and other dCs tracts with varied
sizes will be described in the later section. Results of
cleavage analysis of Cy5-T4B by Endo IV are shown in
Figure 2. Two cleavage bands, marked b and d, corre-
spond to the cleavage products occurred at dC21 and dC26.
Since the b and d bands correspond to the cleavage
product occurred at the dC1 position of 6 dCs tracts,
dC21dA22dC23dT24dT25dC26 and dC26dA27dT28dT29d
G30dC31, respectively, these results are consistent with
and supportive of the 6 dCs tract-dependent polarized
cleavage model. An eﬃcient cleavage at dC21 (marked b)
in a dC21dA22dC23dT24dT25dC26 tract is comparable to
the 6 dCs tract with a third dC mentioned in the previous
section. Another eﬃcient cleavage at dC26 is presumably
due to the presence of dC31 that constitutes a 6 dCs
tract, dC26dA27dT28dT29dG30dC31. To conﬁrm the 6 dCs
6684 Nucleic Acids Research, 2007, Vol. 35, No. 19tract-dependent cleavage at dC26 (marked d in Figure 2),
a derivative of Cy5-T4B, in which the dC31 was replaced
by dG (Cy5-T4BG), was used. If the cleavage event at
dC26 of Cy5-T4B is dependent on the presence of dC31,
Cy5-T4BG does not give a cleavage band marked d in
Figure 2. As shown in Figure 3, a band corresponding to
band d was not detected in Endo IV-treated Cy5-T4BG,
indicating that a dC residue at 31 position (dC31) is crucial
for the cleavage event at dC26, supporting the 6 dCs tract-
dependent polarized cleavage. These results are consistent
with the results obtained by the acid-solubility assay for
dCs tracts and indicating that an eﬃcient cleavage occurs
at dC1 residue depending on the presence of dC6.
Some dCs tractslarger than6bases behaveas
adCs tract cleavable by Endo IV
In addition to the 6 dCs tracts analyzed in the previous
section, Cy5-T4B has a 7 dCs tract having a dC31dG32d
A33dA34dT35dG36dC37, which might be recognized and
cleaved as a dCs tract that is larger than 6 bases. If this
is the case, a dCs tract having 7 or more bases will be
recognized by Endo IV and behaves as an extended
dCs tract.
A dCs tract-dependent polarized cleavage predicts
that cleavages of a substrate having consecutive dCs
tracts cleavable by Endo IV occur in a non-consecutive
manner. That is, a substrate molecule with 2 dCs tracts
consecutively, once cleaved at the 50 proximal dC residue
within 1 dCs tract should destruct a dC tract adjacent to
the cleaved dCs tract. However, if 2 dCs tracts recogniz-
able by Endo IV occur separately (non-consecutively) in
a substrate molecule, once-cleaved molecules will possibly
Figure 1. Cleavage pattern analysis of a T4-based oligonucleotide
Cy5-T4A by Endo-IV. (A) A 45-base oligonucleotide (Cy5-T4A) based
on the T4 DNA and labeled at its 50 end with Cy5 was used as the
substrate at a low Cy5-speciﬁc activity (10mM) for assay of the activity
of varied amount of Endo IV (0.5, 1, 2 or 4mg/ml). The reaction
products were separated by electrophoresis on a 10% polyacrylamide
gel containing 7M urea and were visualized with an image analyzer.
Lane ( ) represents a reaction mixture incubated in the absence of
enzyme. Lane M represnts a mixture of oligonucleotides labeled at their
50 ends with Cy5 and with sequences identical to those of residues 1–19
(a), 1–21 (b) and 1–24 (c) of the substrate. Cleavage bands are shown
by horizontal leftward arrows. (B) A part of Cy5-T4A sequence (from
dT18 to dG27) is shown. Box shows a dC1–dC6 tract with upward
arrows (a, b and c) corresponding to the cleavage sites shown in (A).
Figure 2. Cleavage pattern analysis of a T4-based oligonucleotide
Cy5-T4B by Endo IV. (A) A 45-base oligonucleotide (Cy5-T4B) based
on the sequence of T4 DNA and labeled with its 50 end with Cy5 was
used as the substrate. Lane ( ) represents a reaction mixture without
enzyme. Lane M represents a mixture of oligonucleotides labeled at
their 50 ends with Cy5. Marks b and d indicate bands corresponding to
the cleavage products shown in (B). Others are the same as described
in the legend to Figure 1. (B) A relevant portion of Cy5-T4B sequence
is shown. Two 6 base dCs tracts (dC21dA22dC23dT24dT25dC26 and
dC26dA27dT28dT29dG30dC31) were boxed. Four dC residues within
the sequence which Endo IV might cleave, are shown by arrows (b, c,
d and e).
Figure 3. Cleavage pattern analysis of a T4-based oligonucleotide
Cy5-T4BG by Endo IV. (A) A 45-base oligonucleotide (Cy5-T4BG)
that the dC31 of Cy5-T4B was substituted with dG, was used as the
substrate. Marks b and d with a horizontal arrow indicate the band
positions in the gel corresponding to the cleavage sites (b, c and d)
shown in (B). Others are the same described in Figure 1.
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condition used for the cleavage. Since Cy5-labeled oligo-
nucleotides we used are 50 end-labeled molecules, we may
miss the cleavage products occurred at the 30-proximal
region of a substrate by the secondary cleavage at a
50 proximal dCs tract-dependent cleavage event.
To detect 30-proximal cleavage products, we used an
Endo IV-cleavage condition in which a high speciﬁc Cy5
activity of the oligonucleotides and a lower amount
of enzyme were used (see Materials and Methods section).
As a result, a cleavage band corresponding to the arrow f
(cleaved at dC37) was detected in addition to bands b and
d (Lanes 1, 2 and 3 in Figure 4). In contrast, a cleavage
band corresponding to an arrow e (cleaved at dC31) was
not detected, which would be expected if the 7 dCs tract
(dC31dG32dA33dA34dT35dG36dC37) was cleaved at the
50-proximal dC residue. These results reveal that an appre-
ciable cleavage event did not occur at dC31 in a 7 dCs
tract, dC31dG32dA33dA34dT35dG36dC37 tract-dependent
manner. A dCs tract-dependent and polarized cleavage
at dC37 by a 6 dCs tract (dC37dT38dT39dA40dG41dC42)i s
apparent in the same cleavage products.
In a previous paper (5), we used a Cy5-labeled
oligonucleotide based on phiX174 ssDNA (referred as
Cy5-phiX174-6 in this article) and observed a strong cleav-
age band corresponding to 32-nt long (50-dT1-dG32-30,
band marked c in Figure 5). This cleavage product should
Figure 4. Cleavage pattern analysis of Cy5-T4B derivatives by Endo IV. (A) Three 45-base oligonucleotides (Cy5-T4B, Cy5-T4Be1 and Cy5-T4Be2)
were used as the substrate. Cleavages were done at a high Cy5-speciﬁc activity (10mM/ml) and a low enzyme concentration (0.66mg/ml). Lanes 1 and
2 show cleavage products of Cy5-T4Be2 and Cy5-T4Be1, respectively, corresponding to marks with an arrow b, d and f at the left-hand side.
Lane 3 shows cleavage products of Cy5-T4B by marks with an arrow b, d and f at the right-hand side. Lane 4 represents a reaction mixture
incubated without enzyme. (B) Lower cases (a h) below the sequences of Cy5-T4B, Cy5-T4Be1 and Cy5-T4Be2 represent possible cleavage positions
(dC sites) in each oligonucleotide. Marks with a vertical arrow (b, d and f) correspond to the cleavage products shown in (A). Horizontal arrows with
solid line represent dCs tract cleavable by Endo IV and those with dotted line represent dCs tract non-cleavable by Endo IV.
Figure 5. Cleavage analysis of Cy5-phiX174-6 and Cy5-phiX174-6b by
Endo IV. (A) 45 base Cy5-labeled oligonucleotides based on the
sequence of phiX174 ssDNA [Cy5-phiX174-6 (used in Ref. 5) and its
derivative (Cy5-phiX174-6b) were cleaved by Endo IV]. Cleavages were
done as described in the legend of Figure 4. Lane M represents a
size marker mixture of oligonucleotides labeled at the 50 end with Cy5.
Lanes 1 and 2 represent cleavage products of Cy5-phiX174-6b and
Cy5-phiX174-6, respectively. Bands a, b and c with arrows alongside
the gel correspond to the cleavage sites shown in (B). (B) Nucleotide
sequences of relevant portions in the substrate oligonucleotides Cy5-
phiX174-6b (1) and Cy5-phiX174-6 (2) were shown with possible
cleavage sites (lower cases and vertical arrows) in each sequence.
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7 dCs tract (dC33dA34dC35dG36dT37dT38dC39), if the 7
dCs tract (an extended dCs tract) with a third dC (dC35)
works as a dCs tract cleavable by Endo IV. To know
whether an extended 7 dCs tract-dependent cleavage
occurs or not, two derivatives of Cy5-T4B, named Cy5-
T4Be1 and Cy5-T4Be2, were synthesized and used for
the cleavage analysis by Endo IV. Cy5-T4Be1 is identical
to Cy5-T4B except for an addition of dG between
dC23 and dT24 of Cy5-T4B. Thus, Cy5-T4Be1 has
an extended heptamer dCs tract with a third dC
residue, dC21dA22dC23dG24dT25dT26dC27, being identical
to the 7 dCs tract of phiX174-6 mentioned above. Cy5-
T4Be2 is also a derivative of Cy5-T4Be1 in which a
third dC (dC23) was substituted with a dG residue.
Accordingly, Cy5-T4Be2 has an extended 7 dCs without
a third dC residue. Results of cleavage analysis using
Cy5-T4Be1 and Cy5-T4Be2 were shown in Figure 4.
An appreciable cleavage event (marked b in lane 1,
Figure 4) was observed at dC21 of Cy5-T4Be2 without
a third dC in an extended 7 dCs tract. A cleavage event
at dC21 of Cy5-T4Be1 with a third dC (dC23)i na n
extended 7 dCs tract, was obviously more eﬃcient than
that of Cy5-T4Be2 without a third dC (marked b in
lane 2, Figure 4), indicating that a third dC within
an extended 7 dCs tract has an enhancing eﬀect on
the polarized cleavage at dC1 as suggested by the
acid-solubility assay. This is comparable to the same
eﬀect mentioned previously by a third dC residue in a
basal 6 dCs tract. These results indicate that a 7 dCs
tract having sequence, dCdAdGdGdTdTdC, is cleavable
by Endo IV. Thus, at least one 7 dCs tract having
dCdGdAdAdTdGdC is not cleavable by Endo IV while
the other 7 dCs tract having dCdAdGdGdTdTdC
is cleavable.
Although we do not examine extensively whether dCs
tracts having a longer size than 7 dCs work as a
cleavable target by Endo IV, a 10 dCs tract having
a decameric nucleotide, dC19dT20dT21dA22dA23dT24dA25
dT26dG27dC28 (see Figure 3 of Ref. 5) appears to be
cleaved in an extended dCs tract-dependent manner.
To clarify whether this is true, we did a cleavage analysis
using a Cy5-phiX174-6b, in which the 10th dC from the
cleavage point (dC19) has been substituted with dG.
Results are shown in Figure 5. When the Cy5-phiX174-
6b was cleaved by Endo IV, two bands a and b
disappeared (Lane 1, Figure 5A) and band c remained
unaﬀected. In contrast, the original Cy5-phiX174-6
cleaved by Endo IV gave three cleavage bands, a, b
and c (Lane 2, Figure 5). These results indicate that
the cleavage event at dC19 occurred in a 10 dCs tract-
dependent manner. Although we have not examined
the size limit of dCs tracts cleavable by Endo IV,
a tridecameric nucleotide, dCdTdTdAdAdTdGdTdAdA
dTdTdC, is not cleavable in an apparent dCs tract-
dependent manner (absence of a band in Figure 2,
marked a in Figure 4B). Details of the features of
extended dCs tracts including the size limit and sequence
feature that works as a cleavable tract by Endo IV are
under way and will be published elsewhere.
DISCUSSION
Restricted cleavage ofssDNAs by Endo IV
We have previously demonstrated that highly puriﬁed
Endo IV catalyses endonucleolytic cleavage of ssDNA
speciﬁcally at the 50 phosphodiester bond of dC (5),
consistent with the previous observations (1,3), and that
the eﬃciency of such cleavage is highly dependent on the
identity of the nucleotides surrounding the dC residue (5).
We also observed that the digestion of phiX174 ssDNA,
heat-denatured T4dC genomic dsDNA and a phiX174-
based oligonucleotide by Endo IV was limited (5). Indeed,
the cleavage products of phiX174 ssDNA generated by
Endo IV were largely acid-insoluble under our assay
conditions (5), whereas subsequent treatment of these
products with E. coli exonuclease I rendered them acid-
soluble, as demonstrated for cleavage by partially puriﬁed
Endo IV of fd ssDNA (1,3). These results indicate that
Endo IV does not cleave dC-containing ssDNAs solely
in a dC-speciﬁc manner, but does in a highly restricted
manner.
The basic featureof target sequenceby Endo IV
The cleavage rate and substrate aﬃnity of Endo IV with
[dCdCdCdCdCdC]6/25 were signiﬁcantly higher than
those with [dCdCdCdCdC]5/25, suggesting that the length
of dC-containing sequence is important for an eﬃcient
cleavage by Endo IV. Therefore, we assumed that a 6-base
tract having two dC residues at the ﬁrst and sixth positions
(dC1–dC6 tract) should be crucial for the eﬃcient cleavage
by Endo IV (Figure 6). This was supported by data of the
acid-solubility assay with oligonucleotide substrate that
have the internal positions (dN2 dN5)o fad C 1–dC6 tract
(dC1dN2dN3dN4dN5dC6) replaced with dA, dG or dT
(Tables 2 and 3). It turned out that the Vmax values with
[dCdTdTdTdTdC]6/25, [dCdAdAdAdAdC]6/25 and [dCdG
dGdGdGdC]6/25 were comparable to that with [dCdCd
CdCdCdC]6/25, but signiﬁcantly higher than that with
[dCdCdCdCdC]5/25. Because two dC residues (dC1 and
dC6) in the dC1–dC6 tract largely increase the hydrolysis
rate of Endo IV, it is likely that these two dC residues
contribute to accommodation of the cleavage site to the
active site of Endo IV enzyme, which makes the basic
conﬁguration to be highly susceptible to Endo IV
cleavage. Since the Vmax value with [dCdTdTdTdTd
TdC]7/25 was also comparable to those with [dCdCdCdC
dCdC]6/25 and [dCdCdCdCdCdCdC]7/25 (Table 3), it is
likely that a 7-base (dC1–dC7) tract behaves likewise as
ad C 1–dC6 tract does. All of the dCs tracts having 5 dCs or
shorter examined were not cleavable in a dCs tract-
dependent manner. In contrast, all of the 6 dCs
tracts tested are cleavable by Endo IV while at
least 1 dCs tract having heptamer sequence.
AdCs tract-dependent cleavage occurs exclusively at
thefirst dC residue(dC1) within thedCs tract
The acid-solubility assay revealed that an eﬃcient cleavage
event by Endo IV occurs in a hexameric dCs tract-
dependent manner. To identify the dC residue whose
50 phosphodiester bond is cleaved by Endo IV in the
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analysis using a Cy5-labeled oligonucleotide based on a
T4 DNA sequence (Cy5-T4A) containing a 50-dCdTd
CdTdTdC-30 hexameric dCs tract that is identical to the
target hexamer of [dCdTdCdTdTdC]6/25 used for the acid-
solubility assay in the previous section (Tables 2 and 3).
The cleavage pattern analysis of Cy5-T4A has revealed
that an eﬃcient cleavage occurs almost exclusively at the
ﬁrst dC (dC1) position within the 6 dCs tract. Although
the acid-solubility assay of an oligonucleotide does not
provide information as to sites in which the actual
cleavage event occurred, the result of cleavage pattern
analysis strongly suggests that cleavage event in the
[dCdTdCdTdTdC]6/25 occurred at the ﬁrst dC residue
in the target tract. It is remarkable that an eﬃcient
dC-speciﬁc cleavage occurs exclusively at the dC1 position
within the 6 dCs tract in spite of 3 dC residues possibly
cleavable by Endo IV. A 6 dCs tract-dependent cleavage
at the dC1 position was also conﬁrmed using a set of
Cy5-labeled oligonucleotides, Cy5-T4B and Cy5-T4BG.
Cy5-T4B has two consecutive 6 dCs tracts, dC21dA22d
C23dT24dT25dC26 and dC26dA27dT28dT29dG30dC31, which
is cleaved at dC21 and dC26 corresponding to the dC1
position of respective 6 dCs tract giving two cleavage
bands, b and d (Figure 2). When Cy5-T4BG—i.e. the dC31
residue of Cy5-T4B was replaced with dG—was used,
a cleavage band corresponding to d (see Figure 3)
disappeared. These results indicate that a cleavage event
at the dC26 of Cy5-T4B is depending on the dC31.
Someextended dCs tracts largerthan 6bases function
asatarget dCs tract forthe polarized cleavage by Endo IV,
butsome others do not
We have shown that a 6 dCs (dC1–dC6) tract is basal and
minimal for the dCs tract-depending polarized cleavage by
Endo IV. Moreover, some dCs tracts larger than 6 bases
((dC1–dCx) tract in which x is bigger than 6) behave as
a 6 dCs tract does. Also we have demonstrated that one
7 dCs tract having a sequence dCdAdGdGdTdTdC,
functions as a target dCs tract for polarized cleavage by
Endo IV and that the other 7 dCs tract having a sequence
dCdGdAdAdTdGdC does not function as a cleavable dCs
tract. Another 7 dCs tract having a sequence dCdAdC
dGdTdTdC was eﬃciently cleaved at the dC1 site. So at
least some of 7 dCs tracts are cleavable as an extended dCs
tract by Endo IV but some others are not. Also a 10 dCs
tract having a sequence, dCdTdTdAdAdTdAdTdGdC is
cleavable at the 50-proximal dC position (dC1) (Figure 3
in Ref. 5). When a dC residue at the 30-proximal position
(dC10) is replaced by dG, a cleavage event at the 50-
proximal position (dC1) does not occur, indicating that the
cleavage event at the dC1 position in the 10 dCs tract
occurred in a dCs tract-depending manner and the further
extended dCs tract, having 13 dCs tract, does not.
Twomodes ofdC-specific cleavage by Endo IV:
adCs tract-independent inefficient cleavage and
adCs tract-dependent efficient cleavage
We have previously shown that a dTdCdA is the most
preferable sequence cleaved by Endo IV in a condition in
which an oligonucleotide with a single dC residue is used
as a substrate (5). In this article, we have revealed that an
eﬃcient cleavage by Endo IV occurs exclusively at the
50-proximal position (dC1) within a dCs tract having a
minimal size of 6 bases (a dCs tract-dependent polarized
cleavage). As we discuss in the next section, it is likely
that a dCs tract-dependent cleavage of substrate ssDNA
starts by recognizing a dC residue (‘recruiting dC’) at the
30-proximal position and then scans ‘cut-site dC’ to the
50-direction on the substrate. If the ‘cut-site dC’ is 6 bases
from the ‘recruiting dC’, a cleavage event occurs. Since
a dCs tract-dependent cleavage by Endo IV occurs more
eﬃciently than a dCs tract-independent cleavage does, it
is reasonable to assume that the dCs tract-dependent
cleavage prevails for natural ssDNA substrates. Actually,
when a 45-nt long Cy5-T4A with a single 6 dCs tract was
used, a cleavage band (marked c in Figure 1) presumably
due to a dCs tract-independent cleavage at dTdCdA was
detected, although it was very slight. However, when Cy5-
T4BG with multiple dCs tracts in addition to the relevant
dCs tract (dCdAdCdTdTdC) was used, no cleavage band
(marked d) was detected (Figure 3). These results imply
that a dCs tract-independent cleavage occurs for a sub-
strate where dC residues are very rare. Accordingly, a dCs
tract-dependent cleavage is prevailing for a substrate
DNA having multiple dC residues.
A ‘dCsTract Model’for polarized cleavage by Endo IV
In this article, we have demonstrated that Endo IV cleaves
ssDNAs in a restricted manner in which an eﬃcient
cleavage event occurs exclusively at the dC1 position in a
dCs tract-dependent manner. The minimal size of the dCs
tract recognized by Endo IV is a hexamer (6 dCs tract).
Both the acid-solubility assay and cleavage analysis of
Cy5-labeled oligonucleotides indicated that all of the
6 dCs tracts are cleavable by Endo IV, but less than 6 dCs
tracts are not. Furthermore, at least some dCs tracts larger
than 6 bases and up to at least 10 bases are cleavable in
a dCs tract-dependent manner as extended dCs tracts.
A model explaining the dCs tract-dependent and polarized
cleavage by Endo IV is presented in Figure 6. First of all,
a dC residue in a substrate ssDNA must be recognized
by Endo IV molecule, since cleavage events occur in a dCs
tract-dependent manner. Cleavage events within the
dCs tracts occurring exclusively at the 50-proximal dC
(dC1) and the 30-proximal dC are variable in distance from
the cleavage site dC. Accordingly it is rational to assume
that Endo IV ﬁrst recognizes a dC residue at the
30-proximal position (dC6 or dCx) and that scans a dC
residue to the 50-direction on the substrate. After an Endo
IV molecule binds to the 30-proximal dC as a ‘recruiting
dC’, the enzyme molecule scans the substrate DNA to the
50-direction to ﬁnd a dC residue to be cleaved. If the
50-proximal dC residue locates exactly 6nt apart from
the recruiting dC (dC6 or dCx), a cleavage event occurs at
the dC1 residue (‘cut-site dC’). If a 50-proximal dC residue
locates at less than 6 bases, no cleavage event occurs.
In contrast, if the 50-proximal dC locates apart more than
6nt (extended dCs tracts) from the 30-proximal dC
residue, cleavages occur depending presumably on the
6688 Nucleic Acids Research, 2007, Vol. 35, No. 19sequences composing the extended tract. At least 1 dCs
tract having 10 bases works as a dCs tract cleavable by
Endo IV. A third dC residue within a cleavable dCs tract
may enhance the enzyme-substrate binding or the cleavage
eﬃciency (‘Enhancing dC’) at the ‘cut-site dC’ locating
further to the 50-direction. Recently, we have isolated a
denB mutation whose gene product appears to have
altered the activity of the dCs tract-dependent polarized
cleavage (8). Analysis of the mutant Endo IV may shed
more light on the biological and biochemical signiﬁcance
of the enzyme.
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Figure 6. Schematic representation of ‘dCs Tract Model’ for polarized
cleavage by Endo IV. A basal dC1–dC6 tract (6 dCs tract) is shown
as a horizontal line with two ﬁlled boxes (dC6 and dC1) from 30 to
50 direction. Also, an extended dCs tract is shown by two ﬁlled boxes
(dCx and dC1) in which dCx locates at the extended position from dC1
(apart more than 6 bases from dC1). Endo IV scans ssDNA from 30 to
50 direction and recognizes dC residue (‘Recruiting dC’) at the 30
proximal position of dC1 (‘Cut-site dC’). A cleavage event occurs at the
dC1 residue shown by a vertical arrow when Endo IV ﬁrst binds to
the recruiting dC residue at the dC6 or extended dC position. A dC
residue (dCE) that strengthens dCs tract-dependent cleavage reaction
at dC1 residue is also shown.
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